Artikel ; Online: Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
Journal of pediatric endocrinology & metabolism : JPEM
2016 Band 29, Heft 12, Seite(n) 1345–1352
Abstract: Background: Excessive use of fructose has been incriminated as a risk factor for hepatic steatosis. Procollagen type III N-terminal peptide (P3NP) is a marker for steatohepatitis. Thus, we aimed to assess fructose intake in obese children and its ... ...
Abstract | Background: Excessive use of fructose has been incriminated as a risk factor for hepatic steatosis. Procollagen type III N-terminal peptide (P3NP) is a marker for steatohepatitis. Thus, we aimed to assess fructose intake in obese children and its relation to nonalcoholic fatty liver disease (NAFLD) and P3NP. Methods: Fifty-five obese children were compared to 30 controls. All were subjected to dietary fructose and anthropometric assessment, fasting blood sugar (FBS), fasting insulin (FI) and homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile, uric acid, alanine aminotransferase (ALT), P3NP and abdominal ultrasound. Results: Patients had higher fructose intake which was associated with increased NAFLD grade. There was an increase in P3NP with increased NAFLD grade. P3NP correlated positively with fructose intake (processed sources and total) and caloric intake. Conclusions: High fructose intake is associated with NAFLD and P3NP may serve as a marker of NAFLD in obese children with a proposed cutoff value of 8.5 ng/mL. |
---|---|
Mesh-Begriff(e) | Adolescent ; Anthropometry ; Biomarkers/blood ; Case-Control Studies ; Child ; Cross-Sectional Studies ; Diet/adverse effects ; Energy Intake ; Female ; Fructose/administration & dosage ; Fructose/adverse effects ; Humans ; Insulin Resistance ; Male ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/diagnosis ; Non-alcoholic Fatty Liver Disease/etiology ; Obesity/complications ; Peptide Fragments/blood ; Procollagen/blood ; Prognosis ; Risk Factors ; Sweetening Agents/administration & dosage ; Sweetening Agents/adverse effects |
Chemische Substanzen | Biomarkers ; Peptide Fragments ; Procollagen ; Sweetening Agents ; procollagen Type III-N-terminal peptide ; Fructose (30237-26-4) |
Sprache | Englisch |
Erscheinungsdatum | 2016-12-01 |
Erscheinungsland | Germany |
Dokumenttyp | Comparative Study ; Journal Article |
ZDB-ID | 1231070-0 |
ISSN | 2191-0251 ; 0334-018X |
ISSN (online) | 2191-0251 |
ISSN | 0334-018X |
DOI | 10.1515/jpem-2016-0015 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 2258: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.